Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Lung Cancer
FDA Approvals
,
Lung Cancer
,
Select Drug Profiles
FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation
Play Video
FDA Approvals
,
In the News
,
Lung Cancer
,
Select Drug Profiles
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Play Video
Lung Cancer
Immunotherapies and Lung Cancer
Edward Garon, MD
Play Video
Lung Cancer
Maintenance with Pemetrexed Extends Progression-Free Survival in Advanced Nonsquamous NSCLC
Play Video
Lung Cancer
My Practice: Roles and Responsibilities
Edward Garon, MD
Play Video
Lung Cancer
NCCN Drug Affordability Ratings Miss the Mark in Lung Cancer
Wayne Kuznar
Play Video
Lung Cancer
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Wayne Kuznar
Play Video
In the News
,
Lung Cancer
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Lilly Ostrovsky
Play Video
Lung Cancer
Nivolumab plus Ipilimumab Combination Promotes Durable Responses in Advanced Lung Cancer
Wayne Kuznar
Play Video
Lung Cancer
Non–Small-Cell Lung Cancer Testing Can Be Offered Routinely in Community Hospitals
Wayne Kuznar
Play Video
1
2
3
4
5
Page 3 of 5
Results 21 - 30 of 44